Table 3.
Fibrinolysis (n = 99) | Angioplasty (n = 103) | p Value | |
Primary end points | |||
Death | 9 (9.1%) | 7 (6.8%) | 0.55 |
Reinfarction | 1 (1.0%) | 0 | 0.49 |
Composite (death + reinfarction) | 10 (10.1%) | 7 (6.8%) | 0.39 |
Other cardiac events | |||
Recurrent ischaemia | 17 (17.2%) | 6 (5.8%) | 0.011 |
Heart failure | 13 (13.1%) | 17 (16.5%) | 0.50 |
Inhospital revascularisation | 19 (19.2%) | 6 (5.8%) | 0.004 |
Non-cardiac events | |||
Bleeding (overall) | 15 (15.2%) | 10 (9.7%) | 0.24 |
Bleeding (moderate and severe) | 4 (4.0%) | 5 (4.9%) | 1.00 |
Stroke (haemorrhagic) | 1 (1.0%) | 0 | 0.49 |
Stroke (ischaemic) | 2 (2.0%) | 2 (1.9%) | 1.00 |
Duration of hospitalisation (days (SD)) | 8.21 (4.98) | 7.65 (3.64) | 0.36 |